3628 results for «2253»
3628 results
TAVI in challenging scenarios, diving into real-life cases
12 Sep 2025 – From PCR Rio Valves 2025
Navigate the complexities of challenging TAVI cases through real-life clinical scenarios. This session offers valuable insights into managing complications such as aortic regurgitation, bicuspid valves, valve-in-valve procedures, coronary obstruction, and large annulus with left ventricular outflow tract calcification. Participants will gain practical tips and tricks to...
Orthotopic mitral devices coming soon
12 Sep 2025 – From PCR Rio Valves 2025
This session provides a forward-looking perspective on emerging orthotopic mitral valve devices for repair and replacement. Discussions focus on new device technologies soon to be available, patient selection criteria, and the specific developmental challenges encountered. Case presentations, including the TVMR Intrepid system, illustrate clinical applications and...
Management of residual and recurrent mitral regurgitation after TEER
12 Sep 2025 – From PCR Rio Valves 2025
Delve into the complexities of managing residual and recurrent mitral regurgitation following Transcatheter Edge-to-Edge Repair (TEER). This session discusses challenges such as late mitral regurgitation, strategies for handling single leaflet detachment, and anatomical considerations that may preclude TEER feasibility.
Integrating the newest valve guidelines into daily clinical reality
12 Sep 2025 – From PCR Rio Valves 2025
Integrate the 2025 EACTS valve guidelines into your clinical practice with a focus on valvular heart disease management tailored to Latin American realities. This session reviews the most relevant updates on aortic stenosis management and transcatheter approaches for mitral and tricuspid valves.
Watch the interview with Fabien...
TAVI - Take the first step considering life time management
12 Sep 2025 – From PCR Rio Valves 2025
Understand the critical importance of lifetime management in TAVI, emphasizing how the initial procedure impacts long-term results. This session discusses implantation depth, commissural alignment, and their roles beyond coronary access, illustrated through a low-risk young patient case and current durability data.
From repair to replacement: a portfolio of options for your mitral and tricuspid regurgitation patients
16 Nov 2025 – From PCR London Valves 2025
This session explores a full spectrum of therapeutic options for mitral and tricuspid regurgitation, focusing on the PASCAL Precision system for targeted repair and the SAPIEN M3 transcatheter mitral valve replacement. Through beating heart simulators, case discussions, and clinical evidence, participants will understand the versatility and...
Getting the full potential of the supra-annular valve in a changing landscape
16 Nov 2025 – From PCR London Valves 2025
This session explores the evolving landscape of transcatheter aortic valve implantation (TAVI) with a focus on supra-annular valve technology. It covers techniques for achieving commissural alignment, considerations for small aortic annuli, and advantages in treating bicuspid aortic valve disease, supported by clinical data and illustrative cases.
Hot topics in structural heart: addressing patients' unmet needs with EVOQUE TTVR and SAPIEN THV-in-THV
17 Nov 2025 – From PCR London Valves 2025
This session addresses emerging topics in structural heart disease by examining patient-centered solutions such as EVOQUE transcatheter tricuspid valve replacement (TTVR) and SAPIEN transcatheter heart valve-in-heart valve (THV-in-THV) procedures. It covers the latest data from Europe on redo TAVI, lifetime management strategies beginning with initial prosthesis...
How to optimise TAVI outcomes in extreme patient anatomies?
16 Nov 2025 – From PCR London Valves 2025
Explore strategies to optimise TAVI outcomes in patients with extreme anatomies in this PCR London Valves 2025 session.
Through case-based discussions, the session addresses challenges in small annular anatomy, approaches for large annuli, and strategies to ensure optimal lifetime management for younger TAVI patients. Learn practical tips...
Just CINCH - Indirect annuloplasty for secondary mitral regurgitation in heart failure patients
16 Nov 2025 – From PCR London Valves 2025
This session provides a detailed review of indirect annuloplasty as an interventional treatment for secondary mitral regurgitation in heart failure patients, with a focus on the landmark EMPOWER trial. Learn about patient selection optimisation, procedural considerations involving the coronary sinus and left circumflex artery, and future...
LAA closure is evolving: are you ready?
17 Nov 2025 – From PCR London Valves 2025
This session addresses the evolving landscape of left atrial appendage (LAA) closure in stroke prevention for atrial fibrillation patients. It reviews unmet clinical needs, evaluates the latest evidence and guideline recommendations, and identifies patient populations that benefit most from LAA closure, with discussions on balancing efficacy...
Mastering complex TAVI: overcoming key clinical challenges and achieving optimal outcomes with the Evolut FX+
17 Nov 2025 – From PCR London Valves 2025
This session offers an in-depth review of complex TAVI cases, focusing on overcoming clinical challenges and achieving optimal outcomes with the Evolut FX+ device. Participants will learn about recent advances in TAVI indications for younger and asymptomatic patients, strategies for managing TAV in surgical aortic valve...
Mastering mitral and tricuspid TEER: clinical strategies in patients with complex anatomy
17 Nov 2025 – From PCR London Valves 2025
Find out more about advanced mitral and tricuspid TEER techniques for patients with challenging anatomy. This PCR London Valves 2025 session highlights real-world approaches from the Asia Pacific region, including consensus recommendations from the Asian Pacific Society of Cardiology, strategies for simultaneous mitral TEER and left...
Meet with Myval THV series with real-world case-based learning
17 Nov 2025 – From PCR London Valves 2025
Discover the latest insights from the Myval THV series in this session from PCR London Valves 2025. Through real-world, case-based learning, the session explores lifetime management strategies for TAVI patients, the clinical relevance of intermediate and extra-large valve sizing, and the impact of foreshortening on accurate...
A new era for aortic regurgitation: how new guidelines and dedicated devices for AR will redefine treatment
18 Nov 2025 – From PCR London Valves 2025
This session examines the evolving treatment landscape for aortic regurgitation (AR) in light of new ESC guidelines and dedicated devices such as the JenaValve Trilogy System. It provides an in-depth look at refined diagnosis, optimized treatment strategies, and presents real-world data and clinical cases that highlight...
Advancing structural heart with 3D ICE and device guidance
17 Nov 2025 – From PCR London Valves 2025
This PCR London Valves 2025 session explores how 3D TEE, 3D intracardiac echocardiography (ICE), and DeviceGuide technology sharpen procedural accuracy, strengthen operator confidence, and streamline decision-making in real time.
You’ll see how clearly defined team roles enhance both safety and efficiency, and how thoughtful workflow integration can reduce...
Mitral regurgitation: from guidelines to clinical practice
16 Nov 2025 – From PCR London Valves 2025
This LIVE case symposium brings mitral regurgitation guidelines into real clinical practice. Through step-by-step patient demonstrations and insightful discussion, the session explores how recommendations guide decision-making in ventricular and atrial secondary MR, how the heart team tailors therapy to individual anatomy and comorbidities, and how device iterations...
Myval THV series - Optimise patient outcomes with novel design, data and daily clinical practice
17 Nov 2025 – From PCR London Valves 2025
Discover the essential takeaways from the Myval THV series for improving TAVI outcomes. Learn from high-volume operators how pre-procedural planning, imaging, and sizing rationale guide optimal patient management. See step-by-step implantation of the next-gen Myval Octapro+, including the OctaAlign technique, and understand how precise deployment and...
Open design, confident delivery - How a novel LAA closure device provides predictable outcomes in complex anatomical settings
16 Nov 2025 – From PCR London Valves 2025
This session highlights a novel left atrial appendage (LAA) closure device featuring an open-cage design that delivers predictable clinical and procedural outcomes. It discusses the device's advantages in managing complex anatomical variations and presents implantation techniques across diverse anatomies to improve safety and efficacy.
Align for the future with next gen Myval transcatheter heart valve series
16 Nov 2025 – From PCR London Valves 2025
Discover how the latest Myval transcatheter heart valve (THV) innovations are shaping TAVI outcomes. This PCR London Valves 2025 session highlights the clinical evidence behind the next-gen Myval THV series, best practices for implantation, and upcoming innovations set to improve patient care. Learn step-by-step techniques for deploying Myval...
